These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32414097)

  • 1. Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients.
    Leest PV; Boonstra PA; Elst AT; Kempen LCV; Tibbesma M; Koopmans J; Miedema A; Tamminga M; Groen HJM; Reyners AKL; Schuuring E
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling.
    van der Leest P; Ketelaar EM; van Noesel CJM; van den Broek D; van Boerdonk RAA; Deiman B; Rifaela N; van der Geize R; Huijsmans CJJ; Speel EJM; Geerlings MJ; van Schaik RHN; Jansen MPHM; Dane-Vogelaar R; Driehuis E; Leers MPG; Sidorenkov G; Tamminga M; van Kempen LC; Schuuring E
    Clin Chem; 2022 Jul; 68(7):963-972. PubMed ID: 35616097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
    Lampignano R; Neumann MHD; Weber S; Kloten V; Herdean A; Voss T; Groelz D; Babayan A; Tibbesma M; Schlumpberger M; Chemi F; Rothwell DG; Wikman H; Galizzi JP; Riise Bergheim I; Russnes H; Mussolin B; Bonin S; Voigt C; Musa H; Pinzani P; Lianidou E; Brady G; Speicher MR; Pantel K; Betsou F; Schuuring E; Kubista M; Ammerlaan W; Sprenger-Haussels M; Schlange T; Heitzer E
    Clin Chem; 2020 Jan; 66(1):149-160. PubMed ID: 31628139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows.
    Lehle S; Emons J; Hack CC; Heindl F; Hein A; Preuß C; Seitz K; Zahn AL; Beckmann MW; Fasching PA; Ruebner M; Huebner H
    Sci Rep; 2023 Jan; 13(1):373. PubMed ID: 36611077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
    Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
    Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis.
    Huebner H; Lubrich H; Blum S; Antoniadis S; Lermann J; Ekici A; Fasching PA; Beckmann MW; Ruebner M; Burghaus S
    Reprod Biomed Online; 2021 Nov; 43(5):788-798. PubMed ID: 34493460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of commercial kits for purification of circulating free DNA.
    Diefenbach RJ; Lee JH; Kefford RF; Rizos H
    Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
    J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality.
    Terp SK; Pedersen IS; Stoico MP
    J Mol Diagn; 2024 Apr; 26(4):310-319. PubMed ID: 38336350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of Circulating Cell-Free DNA from Plasma and Urine Using the Automated Large-Volume Extraction on the QIAsymphony® SP Instrument.
    Wolf A; Beller K; Groemminger S; Hofmann W; Sachse M; Fassunke J
    Adv Exp Med Biol; 2016; 924():179-185. PubMed ID: 27753041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis.
    Till JE; Black TA; Gentile C; Abdalla A; Wang Z; Sangha HK; Roth JJ; Sussman R; Yee SS; O'Hara MH; Thompson JC; Aggarwal C; Hwang WT; Elenitoba-Johnson KSJ; Carpenter EL
    J Mol Diagn; 2021 Nov; 23(11):1545-1552. PubMed ID: 34454115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients.
    Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing.
    Pérez-Barrios C; Nieto-Alcolado I; Torrente M; Jiménez-Sánchez C; Calvo V; Gutierrez-Sanz L; Palka M; Donoso-Navarro E; Provencio M; Romero A
    Transl Lung Cancer Res; 2016 Dec; 5(6):665-672. PubMed ID: 28149760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of Cell-Free DNA from Maternal Plasma.
    Stray J; Zimmermann B
    Methods Mol Biol; 2019; 1885():309-323. PubMed ID: 30506207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing.
    Hellwig S; Nix DA; Gligorich KM; O'Shea JM; Thomas A; Fuertes CL; Bhetariya PJ; Marth GT; Bronner MP; Underhill HR
    PLoS One; 2018; 13(7):e0197333. PubMed ID: 30044795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Evaluation of the Factors Affecting Plasma Circulating Cell-Free DNA Levels and Their Application in Diagnosing Nonsmall Cell Lung Cancer.
    Chen Z; Zhang S; Li C; Xu C; Zhao J; Miao L
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):270-276. PubMed ID: 30986099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA.
    Ottaviano M; Giuliano M; Tortora M; La Civita E; Liotti A; Longo M; Bruzzese D; Cennamo M; Riccio V; De Placido P; Picozzi F; Parola S; Daniele B; Botti G; Formisano P; Beguinot F; De Placido S; Terracciano D; Palmieri G
    Front Oncol; 2020; 10():602153. PubMed ID: 33634024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience.
    Malentacchi F; Pizzamiglio S; Verderio P; Pazzagli M; Orlando C; Ciniselli CM; Günther K; Gelmini S
    Clin Chem Lab Med; 2015 Nov; 53(12):1935-42. PubMed ID: 25883202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
    Nesic M; Bødker JS; Terp SK; Dybkær K
    Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.